Are chemogenetics really a miracle tool?
Leah Fogarty explores the use of chemogenetics in the treatment of neurological conditions, such as epilepsy, ADHD, and Parkinson’s disease.
In the column Brainwaves, Leah Fogarty delves into a spectrum of neuroscience opinions, ranging from attitudes towards psychiatric conditions to new developments in machine learning and challenges faced when investigating the brain.
Leah Fogarty explores the use of chemogenetics in the treatment of neurological conditions, such as epilepsy, ADHD, and Parkinson’s disease.
Leah Fogarty discusses the complexities and urgent need for research on Capgras delusion, a poorly understood psychiatric condition.